Detalles de la búsqueda
1.
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective.
Support Care Cancer
; 30(11): 9307-9315, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36074186
2.
Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey.
Cancer Rep (Hoboken)
; 1(4): e1127, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729252
3.
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.
Drugs Context
; 4: 212285, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26322114
Resultados
1 -
3
de 3
1
Próxima >
>>